RxDoctor Payments Data

Alexander Jehle, MD

Cardiovascular Disease · Missoula, MTNPI 1790831329

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (58.7%), food and beverage and education — rather than concentrated in one kind of arrangement. Abbott accounts for 83.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,568 and has fallen 97.1% since, to $45 in 2024.

$1,833in general payments, 2019–2025

Across 33 payments — averaging $55.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • GE HealthCare$88
  • Medtronic$77
  • Heartflow, Inc.$61
  • Boston Scientific$32
  • Sumitomo Pharma America, Inc.$13
  • plus $25 from 2 others

What the payments were for

  • Travel & lodging$1,07559%
  • Food & beverage$74541%
  • Education$121%

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,833 in reported general payments places this provider in the 55th percentile of 49 cardiovascular disease providers in Montana.

See all cardiovascular disease providers in Montana

Medicare billing

Part B allowed, 2024
$152,059
Medicare patients
1,956
Services billed
2,713

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban152$190,672
XareltoRivaroxaban32$41,104
JardianceEmpagliflozin26$39,239
EntrestoSacubitril/Valsartan27$35,857
Metoprolol Succinate255$4,117
Atorvastatin Calcium308$3,366
Ezetimibe95$2,059
Rosuvastatin Calcium209$1,932
Potassium Chloride49$1,534
Losartan Potassium149$1,255
Carvedilol158$1,166
Lisinopril138$955
Amlodipine Besylate114$679
Valsartan42$609
Irbesartan14$527

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →